BIONTECH : UBS sticks Neutral - dofaq.co
BIONTECH : UBS sticks Neutral
marketscreener.com - 27 Nov 2023
Eliana Merle from UBS retains his Neutral opinion on the stock. The target price has been revised downwards and is now set at USD 110 as compared to USD 153 ...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters - 25 Apr 2024
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology ...
Comparing the COVID-19 Vaccines: How Are They Different?
Yale Medicine - 24 Apr 2024
Comparing the COVID-19 Vaccines: How Are They Different? ...
GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit
FiercePharma - 26 Apr 2024
GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit ...
BioNTech mRNA Vaccine Manufacturing Facility, Rwanda
Pharmaceutical Technology - 24 Apr 2024
BioNTech mRNA Vaccine Manufacturing Facility, Rwanda ...
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement
BioSpace - 26 Apr 2024
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement ...
What We're Reading: Kaiser Permanente Data Breach; GSK Sues Pfizer, BioNTech; HIV Infections via Cosmetic ...
AJMC.com Managed Markets Network - 26 Apr 2024
What We're Reading: Kaiser Permanente Data Breach; GSK Sues Pfizer, BioNTech; HIV Infections via Cosmetic ... ...
GSK: Pfizer, BioNTech 'reaped billions of dollars' from stealing COVID-19 patents
Life Sciences Intellectual Property Review - 26 Apr 2024
GSK: Pfizer, BioNTech 'reaped billions of dollars' from stealing COVID-19 patents ...
GSK Hits Pfizer And BioNTech With COVID Vaccine Patent Suit
Law360 - 26 Apr 2024
GSK Hits Pfizer And BioNTech With COVID Vaccine Patent Suit ...
Recon: Senate committee probes Novo's Ozempic and Wegovy pricing; GSK sues Pfizer, BioNTech over COVID ...
Regulatory Focus - 25 Apr 2024
Recon: Senate committee probes Novo's Ozempic and Wegovy pricing; GSK sues Pfizer, BioNTech over COVID ... ...
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer - On Cancer
Memorial Sloan Kettering - 07 Apr 2024
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer ...
Covid vaccine makers to clash in London over mRNA patent dispute
Financial Times - 22 Apr 2024
Covid vaccine makers to clash in London over mRNA patent dispute ...
GSK sues Pfizer and BioNTech over mRNA billions
The Pharma Letter - 26 Apr 2024
GSK sues Pfizer and BioNTech over mRNA billions ...
AACR 24: BioNTech cancer vax spurs immune response 3 years in
Fierce Biotech - 07 Apr 2024
AACR 24: BioNTech cancer vax spurs immune response 3 years in ...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters - 23 Apr 2024
Pfizer vs Moderna battle over COVID vaccine patents begins in UK ...
Pfizer and BioNTech commence legal action against Moderna in UK court
Pharmaceutical Technology - 24 Apr 2024
Pfizer and BioNTech commence legal action against Moderna in UK court ...
Pfizer, BioNTech win pause in patent infringement case from rival Moderna
FiercePharma - 15 Apr 2024
Pfizer, BioNTech win pause in patent infringement case from rival Moderna ...
BioNTech Hit with NIH Notice of Default Over COVID-19 Vaccine Royalties
BioSpace - 26 Mar 2024
BioNTech Hit with NIH Notice of Default Over COVID-19 Vaccine Royalties ...
BioNTech gets US agency notice over default on COVID vaccine royalties
Reuters - 25 Mar 2024
BioNTech gets US agency notice over default on COVID vaccine royalties ...
After earnings plunge, BioNTech pins hopes on cancer drug launches
Reuters - 20 Mar 2024
After earnings plunge, BioNTech pins hopes on cancer drug launches ...